NO910901L - Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser. - Google Patents

Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.

Info

Publication number
NO910901L
NO910901L NO91910901A NO910901A NO910901L NO 910901 L NO910901 L NO 910901L NO 91910901 A NO91910901 A NO 91910901A NO 910901 A NO910901 A NO 910901A NO 910901 L NO910901 L NO 910901L
Authority
NO
Norway
Prior art keywords
treatment
obesitas
essential hypertension
related disorders
hypertension
Prior art date
Application number
NO91910901A
Other languages
English (en)
Norwegian (no)
Other versions
NO910901D0 (no
Inventor
Garth J S Cooper
Brendan Leighton
Original Assignee
Amylin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Corp filed Critical Amylin Corp
Publication of NO910901D0 publication Critical patent/NO910901D0/no
Publication of NO910901L publication Critical patent/NO910901L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO91910901A 1989-07-10 1991-03-07 Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser. NO910901L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37765289A 1989-07-10 1989-07-10
PCT/US1990/003795 WO1991000737A1 (en) 1989-07-10 1990-07-10 Treatment of obesity and essential hypertension and related disorders

Publications (2)

Publication Number Publication Date
NO910901D0 NO910901D0 (no) 1991-03-07
NO910901L true NO910901L (no) 1991-04-25

Family

ID=23490003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910901A NO910901L (no) 1989-07-10 1991-03-07 Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.

Country Status (14)

Country Link
EP (1) EP0408294B1 (ja)
JP (1) JPH04500688A (ja)
AT (1) ATE128032T1 (ja)
AU (1) AU620727B2 (ja)
CA (1) CA2020786A1 (ja)
DE (1) DE69022501T2 (ja)
DK (1) DK0408294T3 (ja)
ES (1) ES2080802T3 (ja)
FI (1) FI911179A7 (ja)
GR (1) GR3018442T3 (ja)
IE (1) IE71195B1 (ja)
NO (1) NO910901L (ja)
NZ (1) NZ234428A (ja)
WO (1) WO1991000737A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
EP0503827A1 (en) * 1991-03-15 1992-09-16 Pfizer Inc. Amylin and calcitonin gene-related peptide use and antagonists thereof
SG49239A1 (en) * 1991-05-24 1998-05-18 Amylin Pharmaceuticals Inc Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
CA2100745C (en) * 1991-11-19 2007-07-31 Laura S. L. Gaeta Amylin agonist peptides and uses therefor
WO1993019774A1 (en) * 1992-04-03 1993-10-14 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
NZ253449A (en) * 1992-05-15 1994-12-22 Amylin Pharmaceuticals Inc Monoclonal antibody binding to the c-terminal end of human amylin and kits and assays employing it
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
US5625032A (en) * 1993-07-21 1997-04-29 Amylin Pharmaceuticals, Inc. Selective amylin antagonist peptides and uses therefor
WO1996003993A2 (en) * 1994-08-05 1996-02-15 The Rockefeller University Modulation of thymocyte and t cell functional activity
US6187991B1 (en) * 1995-05-23 2001-02-13 Pfizer Inc Transgenic animal models for type II diabetes mellitus
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO2000078805A1 (en) * 1999-06-18 2000-12-28 Protemix Corporation Limited Peptide having preptin functionality
EP3069731A1 (en) 2005-11-14 2016-09-21 Labrys Biologics Inc. Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
RU2522493C2 (ru) 2008-03-04 2014-07-20 Пфайзер Лимитед Способы лечения хронической боли
CN102740884A (zh) 2009-08-28 2012-10-17 瑞纳神经科学公司 通过施用针对降钙素基因相关肽的拮抗性抗体来治疗内脏痛的方法
EP2493919A1 (en) * 2009-10-30 2012-09-05 Novo Nordisk A/S Derivatives of cgrp
IL243355B2 (en) * 2013-07-03 2024-10-01 Lundbeck Seattle Biopharmaceuticals Inc Regulation of glucose metabolism using anti-cgrp antibodies
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
AU2015230933B2 (en) 2014-03-21 2020-08-13 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
CN109952314A (zh) 2016-09-23 2019-06-28 泰瓦制药国际有限公司 治疗难治性偏头痛

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049654A (en) * 1986-12-04 1991-09-17 Toyo Jozo Kabushiki Kaisha Calcitonin gene related peptide derivatives
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
AU631112B2 (en) * 1988-01-11 1992-11-19 Amylin Corporation Treatment of type 2 diabetes mellitus

Also Published As

Publication number Publication date
JPH04500688A (ja) 1992-02-06
IE902514A1 (en) 1991-02-13
FI911179A0 (fi) 1991-03-08
EP0408294A3 (en) 1991-12-18
NO910901D0 (no) 1991-03-07
EP0408294B1 (en) 1995-09-20
WO1991000737A1 (en) 1991-01-24
DK0408294T3 (da) 1996-01-15
AU620727B2 (en) 1992-02-20
CA2020786A1 (en) 1991-01-11
ATE128032T1 (de) 1995-10-15
ES2080802T3 (es) 1996-02-16
DE69022501T2 (de) 1996-02-01
GR3018442T3 (en) 1996-03-31
IE71195B1 (en) 1997-02-12
DE69022501D1 (de) 1995-10-26
FI911179A7 (fi) 1991-03-08
NZ234428A (en) 1997-08-22
AU5953790A (en) 1991-02-06
EP0408294A2 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
NO910901L (no) Behandling av obesitas og essensiell hypertensjon og relaterte forstyrrelser.
IT1236541B (it) Procedimento ed apparecchiatura per il trattamento di lastre di vetro.
ATE279517T1 (de) Il-17 receptor
FR2553287B1 (fr) Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
ATE81135T1 (de) Aktive thymopentin-analoga.
FI904735A0 (fi) Anordning foer maetning av tryckdifferens.
IT8468197A1 (it) Procedimento per la formazione di cataste di oggetti tubolari o simili, e dispositivo per la sua attuazione.
DE69123970D1 (de) Ehv-4 glykoprotein vazin
ES2067541T3 (es) Mejoras en antagonistas de la serotonina y relacionadas con ellos.
IT8122288A0 (it) Procedimento di mantenimento della coesione di un carico e carico risultante dalla messa in opera del procedimento.
FR2598140B1 (fr) Ascenseur pour le transport des personnes.
FI914064A0 (fi) Foerfarande foer framstaellning av peptider med hjaelp av fastfassyntes.
DE59005635D1 (de) Weichen und kreuzungen von hängebahnen-transportschienenanlagen.
TR26158A (tr) Jeotermal kuyularin isletilmesi icin usul ve ter- tibat.
DE59007354D1 (de) Monohydrochlorid und Monomethansulfonat von Amonafide.
ES2157261T3 (es) Familia de peptidos denominados xenoninas.
IT1211763B (it) Procedimento per la separazione di tallio da piombo d'opera e piombo raffinato
NO951250L (no) Amylin-antagonist og fremgangsmåte for screening derav
ITBO910203A1 (it) Dispositivo per la formatura di calze e simili.
IT1201267B (it) Un agente che favorisce l'erezione e la fecondita' un metodo per produrre tale agente ad impiego dell'agente stesso nella produzione di composizioni che favoriscono l'erezione e la fecondita'
IT8821442V0 (it) Scatola protettiva per apparecchiature per la determinazione del carico di rottura di fiale preincise e simili.
IT8919554A0 (it) Procedimento per la formatura di pannelli isolanti in fibra di vetro o minerale e dispositivo automatico per l'attuazione del procedimento.
IT8947558A0 (it) Dispositivo da tavolo per l'estrazione singola di fogli per annotazioni e simili
IT9021854A0 (it) Dispositivo per la regolazione ed il bloccaggio dell'inclinazione del piano di lavoro di tavoli da disegno e simili.
IT8547774A0 (it) Dispositivo per la cattura e il convogliamento di asbesto ed altri materiali derivati da torni di rettifica e simili